Found 17 matching trials
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients PHASE3 To prove that the efficacy and safety of 'Green Cross CELL\* Immuncell-LC g...
Show More Location
Korea University Ansan Hospital
Learn More & Join Trial
Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer PHASE2 This randomized, multicenter,open-label phase II/III study is to evaluate t...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating PHASE2 The purpose of this study is to show if vaccination with autologous dendrit...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC PHASE1 This prospective, unicentric, open-labe phase I study is to evaluate the ef...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma PHASE2 This randomized, multicenter,open-label, phase II study is to evaluate the ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT PHASE1 Allogeneic hematopoietic cell transplantation(Allo-HSCT) is currently an ef...
Show More Location
Department of Hematopoietic Stem Cell Transplantation
Learn More & Join Trial
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma PHASE1 The purpose of this study is to show if vaccination with autologous dendrit...
Show More Location
Fuzhou General Hospital
Learn More & Join Trial
A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma PHASE4 This clinical trial is designed to provide one kind of modalities for preve...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced Bladder Cancer N/A We plan to enroll 20-29 patients with advanced bladder cancer to undergo T-...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer. EARLY_PHASE1 Research background and purpose:
Patients with advanced colorectal cancer ...
Show More Learn More & Join Trial